Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dilba
New York City, New York, United Statesdilba-therapy.com ↗
- Ownership
- Private
- Employees
- ~32
- Development stage
- Other
01
Overview
DiLab is a provider of automated blood sampling systems used in preclinical pharmacokinetic and toxicology studies. Their flagship product, the AccuSampler®, enables fully automated collection of blood samples from tethered or freely moving laboratory animals. The company’s technology is widely adopted by pharmaceutical companies for improving the efficiency and accuracy of drug development studies.
- Therapeutic areas
- Other
- Modalities
- DeviceAutomated blood sampling system (research tool)
- Industry
- Drug Discovery Services
02
Partnerships
Novo Nordisk A/S (collaborative project in the 1990s to develop automated blood collection instruments)
Beyond the preview
Go deeper on Dilba.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dilba.